Evidence map›Paper›PMID 31331298›Full record

ArticleBMC ophthalmology2019

Macular hole retinal detachment after intravitreal Conbercept injection for the treatment of choroidal neovascularization secondary to degenerative myopia: a case report.

Chuan-Bin Sun, Yueye Wang, Shiyang Zhou, Xudong Fang, Danni Xu, Zhe Liu

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Acute and delayed full thickness macular holes in patients with intravitreal VEGF-inhibitors therapy.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Chuan-Bin SunEye Center, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China.
Yueye WangEye Center, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China.
Shiyang ZhouEye Center, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China.
Xudong FangEye Center, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China.
Danni XuEye Center, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, China.
Zhe LiuDepartment of Ophthalmology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310015, China. doctorliuzhe@126.com.
Second Affiliated Hospital of Zhejiang University · CNZhejiang Provincial People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe report a case of macular hole (MH) formation and retinal detachment after intravitreal conbercept injection for the treatment of choroidal neovascularization (CNV) secondary to degenerative myopia. CASE PRESENTATION: A 60-year-old woman presented with blurred vision in her left eye was diagnosed as CNV secondary to degenerative myopia. Intravitreal injection of conbercept, an anti -vascular endothelial growth factor (VEGF) agent, was uneventfully performed in the left eye. Unfortunately, a full thickness MH and retinal detachment was found three weeks postoperatively by ophthalmoscopy and spectral-domain optical coherence tomography. Vitrectomy, internal limiting membrane peeling and silicone oil tamponade were then performed, and macular retina was reattached soon after surgery. However, MH still kept open during three months' follow-up.

conclusionMH is a quite rare complication of intravitreal anti- VEGF agent injection, tangential contraction secondary to CNV shrinkage and regression caused by anti-VEGF agent is proposed to be the major pathogenesis of MH formation.

Indexed as

Angiogenesis InhibitorsChoroidal NeovascularizationFemaleHumansIntravitreal InjectionsMiddle AgedMyopia, DegenerativeRecombinant Fusion ProteinsRetinal DetachmentRetinal PerforationsAngiogenesis InhibitorsKH902 fusion proteinRecombinant Fusion ProteinsChoroidal neovascularizationConberceptDegenerative myopiaIntravitreal injectionMacular hole

Identifiers

PMID31331298
PMCPMC6647155
OpenAlexW2963220880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.